Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza. (Q46971184)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 September 2011

Language	Label	Description	Also known as
English	Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.	scientific article published on 20 September 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

0 references

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Nand Kishore Gupta

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Priti Tomar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Vikas Sharma

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

0 references

publication date

20 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

48

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

9026-9037

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Current and future antiviral therapy of severe seasonal and avian influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

H1N1 2009 influenza virus infection during pregnancy in the USA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Neuraminidase inhibitors for influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Prevention and treatment of influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

The annual production cycle for influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Chitosan as a novel nasal delivery system for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

The biopharmaceutical aspects of nasal mucoadhesive drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

New strategies for using mucosal vaccination to achieve more effective immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Evaluation of the clearance characteristics of bioadhesive systems in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Nasal drug delivery--possibilities, problems and solutions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

The performance of nanocarriers for transmucosal drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Exploiting M cells for drug and vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Chitosan and the mucosal delivery of biotechnology drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Chitosan microspheres as a potential carrier for drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Preparation and characterization of chitosan and trimethyl-chitosan-modified poly-(epsilon-caprolactone) nanoparticles as DNA carriers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

A sensitive ELISPOT assay to detect low-frequency human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

A novel bioadhesive intranasal delivery system for inactivated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Preparation and purification of cationic solid lipid nanospheres--effects on particle size, physical stability and cell toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Aspects of the Design and Delivery of Microparticles for Vaccine Applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Effects of different N-trimethyl chitosans on in vitro/in vivo ofloxacin transcorneal permeation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

IgG2a restriction of murine antibodies elicited by viral infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

The IgG subclass responses to influenza virus haemagglutinin in the mouse: effect of route of inoculation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Host defense mechanisms at mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

NALT- versus Peyer's-patch-mediated mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Bronchus- and nasal-associated lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.09.033

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46971184&oldid=1369010529"